Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Divalproex CR
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Bipolar disorder (mania, mixed states, maintenance)
- Complex partial seizures
- Migraine prophylaxis (FDA approved)
Mechanism of Action
Sodium Valproate is a broad-spectrum AED — increases GABA levels (inhibits GABA transaminase), blocks voltage-gated sodium channels, and inhibits T-type calcium channels. Also used as mood stabiliser in bipolar disorder and migraine prophylaxis.
Dosage & Administration
- Adults: 300–600 mg twice daily.
Side Effects
- Tremor, weight gain, hair loss (alopecia), hepatotoxicity (severe in children <2 years), pancreatitis, thrombocytopenia, teratogenicity (neural tube defects).
Contraindications
- Pregnancy (CATEGORY X — teratogenic), hepatic dysfunction, urea cycle disorders, mitochondrial disorders, children <2 years on polytherapy.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Strip)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet?
Available pack sizes include: 10 x 10 (Strip).
What is the MRP / trade price for Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet?
MRPs range from ₹682 to ₹682 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Sodium Valporate 200 mg + Valporic Acid 87 mg (CR) (300 mg) (Both together corressponds to Sodium Valporate 300 mg) Tablet?